Evidence map›Paper›PMID 33007187›Full record

ReviewCanadian Urological Association journal = Journal de l'Association des urologues du Canada2021

Clinical dilemmas in local and regional testis cancer.

Gregory J Nason, Ricardo A Rendon, Lori Wood, Robert A Huddart, Peter Albers, Lawrence H Einhorn, Craig R Nichols, Christian Kollmannsberger, Lynn Anson-Cartwright, Padraig Warde and 5 more

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Gregory J NasonDivision of Urology, Department of Surgery, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Ricardo A RendonDepartment of Urology, Dalhousie University, Halifax, NS, Canada.
Lori WoodDivision of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Robert A HuddartThe Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
Peter AlbersDepartment of Urology, Heinrich-Heine University, Medical Faculty, Düsseldorf, Germany.
Lawrence H EinhornDepartment of Oncology, Indiana University School of Medicine, Indianapolis, IN, United States.
Craig R NicholsTesticular Cancer Multidisciplinary Clinic, Virginia Mason Medical Center, Seattle, WA, United States.
Christian KollmannsbergerBritish Columbia Cancer Agency Vancouver Cancer Centre, University of British Columbia, Vancouver, BC, Canada.
Lynn Anson-CartwrightDivision of Urology, Department of Surgery, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Padraig WardeDepartment of Radiation Oncology, Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
Michael A S JewettDivision of Urology, Department of Surgery, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Peter ChungDepartment of Radiation Oncology, Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
Philippe L BedardDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Aaron R HansenDivision of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Robert J HamiltonDivision of Urology, Department of Surgery, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Princess Margaret Cancer Centre · CADalhousie University · CAHeinrich Heine University Düsseldorf · DEInstitute of Cancer Research · GBQueen Elizabeth II Health Sciences Centre · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the Canadian Testis Cancer Workshop, the multidisciplinary management of testis cancer care was discussed. The two-day workshop involved urologists, medical and radiation oncologists, pathologists, radiologists, physician's assistants, residents, fellows, nurses, patients, and patient advocacy group members.This review summarizes the discussion regarding clinical dilemmas in local and regional testis cancer. We present cases that highlight the need for a coordinated approach to individualize care. Overarching themes include the importance of a multidisciplinary approach to testis cancer, willingness to involve a high-volume experienced center, and given that the oncological outcomes are excellent, a reminder that clinical decisions need to prioritize selecting a strategy with the least treatment-related morbidity when safe.

Identifiers

PMID33007187
PMCPMC7769526
OpenAlexW3091174319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.